Inhibitors of serine protease, particularly hepatitis C virus NS3-NS4A protease, incorporating a fused ring system

Details for Australian Patent Application No. 2002348414 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Van Drie, John, H.; Pernie, Robert, B.; Farmer, Luc, J.; Pitlik, Janos

Agent Cullen & Co

Pub. Number AU-B-2002348414

PCT Number PCT/US02/34248

PCT Pub. Number WO2003/035060

Priority 60/343,862 24.10.01 US

Filing date 24 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 1 October 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/7052 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/023 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 60/343,862 24.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002348414

3 November 2005 Amendment Made

  The nature of the amendment is: Delete co-applicants Robert B. Pernie, Janos Pitlik and John H. Van Drie 2003

1 October 2009 Application Accepted

  Published as AU-B-2002348414

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002348415-A method and system for modeling, analysis and display of network security events

2002348413-SEMICONDUCTOR PACKAGE HAVING MULTI-SIGNAL BUS BARS